Neogap opens the door to groundbreaking cancer treatment
Neogap has developed software and a treatment method to distinguish between healthy tissue and cancer. The immunotherapy company has now been granted a grant from the EU.
Our newsletter focuses primarily on life science and highlights key players, topics and development within the innovation ecosystem in the Stockholm-Uppsala region.
